Roche raised hopes this year that it had a future blockbuster drug on its hands after early trial results of the Swiss pharmaceutical group’s new obesity treatments showed rapid weight loss among recipients.
罗氏(Roche)今年让人们对其未来的重磅药物充满希望，因为这家瑞士制药集团的新型肥胖症治疗药物在早期试验中显示出接受者体重迅速下降。
您已阅读3%（274字），剩余97%（8012字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。